{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:11025495",
      "entity_text" : "cholesterol",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:HDL",
      "entity_text" : "HDL",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The cholesterol efflux rate in the peritoneal macrophages and hepatocytes from the rabbits in the atherosclerosis group was significantly lower than that in the control group rabbits (peritoneal macrophages : 16.48 +/-4.10 vs. 24.93 +/-3.85%, P < 0.01; hepatocytes : 3.25 +/-0.97 vs. 5.29 +/-1.71%, P < 0.05), while the peritoneal macrophages and hepatocytes from the rabbits treated with rosiglitazone showed a significantly enhanced HDL induced cholesterol efflux as compared with the atherosclerosis group (peritoneal macrophages : 44.50 +/-6.19 vs. 16.48 +/-4.10%, P < 0.01; hepatocytes : 8.50 +/-1.18 vs. 3.25 +/-0.97%, P < 0.01; XREF_FIG).",
  "reading_complete" : "2020-08-03T16:55:29Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:54:20Z",
  "trigger" : "induced",
  "evidence" : [ "HDL-induced cholesterol" ],
  "pmc_id" : "4314417",
  "score" : 0
}